TAM
AZN icon

Tucker Asset Management’s AstraZeneca AZN Stock Holding History

Tucker Asset Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,013
Closed -$186K – 430
2025
Q4 		$186K Buy
+1,013
New +$178K 0.05% 121
2025
Q1 		– Sell
-1,694
Closed -$222K – 366
2024
Q4 		$222K Buy
1,694
+316
+23% +$44.2K 0.02% 123
2024
Q3 		$215K Buy
1,378
+270
+24% +$43.6K 0.05% 135
2024
Q2 		$173K Buy
1,108
+1,093
+7,287% +$164K 0.04% 178
2024
Q1 		$2.03K Sell
15
-21
-58% -$2.78K ﹤0.01% 1308
2023
Q4 		$4.78K Sell
36
-2
-5% -$260 ﹤0.01% 926
2023
Q3 		$5.08K Hold
38
– – ﹤0.01% 818
2023
Q2 		$5.37K Sell
38
-412
-92% -$60.6K ﹤0.01% 663
2023
Q1 		$62.4K Buy
450
+427
+1,857% +$57.4K 0.02% 215
2022
Q4 		$3.06K Hold
23
– – ﹤0.01% 506
2022
Q3 		$2.65K Buy
23
+2
+10% +$254 ﹤0.01% 527
2022
Q2 		$2.71K Hold
21
– – ﹤0.01% 417
2022
Q1 		$2.72K Buy
+21
New +$2.52K ﹤0.01% 390

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Asset Management
Vanguard Asset Management London, Ec4n 8af $148B AUM

Tucker Asset Management's AZN Position: Q1 2026 in Review

Tucker Asset Management sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 1,013 shares — an estimated $186K sold.

Tucker Asset Management first reported a position in AZN in Q1 2022 and held it in 13 quarters. The position peaked at $222K in Q4 2024. 1,386 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Tucker Asset Management reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Tucker Asset Management sold 1,013 AstraZeneca shares in Q1 2026, an estimated $186K.
  • Tucker Asset Management first reported a position in AstraZeneca in Q1 2022 and held it in 13 quarters.
  • Tucker Asset Management's AstraZeneca position peaked at $222K in Q4 2024.
  • 1,386 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Tucker Asset Management's 13F filing for Q1 2026, filed 27 Aug 2026.